NIH Accused of Secretly Testing Experimental RSV Vaccine on Black Infants in 1960s

3

Allegations of Non-Consensual Medical Experimentation

The federal lawsuit, filed on behalf of the families of Ross Otto Hambrick and Victor Marcellus King, centers on a series of experimental vaccine studies conducted between 1965 and 1966. According to the complaint filed by Ben Crump Law, these infants were enrolled in a government-sponsored trial for a vaccine candidate designated as “Lot 100.” Both infants subsequently died in January 1967. Attorneys for the families allege that the National Institutes of Health intentionally selected vulnerable Black infants from low-income backgrounds for these trials. The lawsuit asserts that the families were never informed of the experimental nature of the procedures, nor did they provide any form of informed consent. Furthermore, the legal team claims that tissue samples harvested during autopsies of the infants were later used to facilitate the development of RSV vaccines that eventually gained FDA approval in 2023.

“The legal team is seeking justice on behalf of the Hambrick and King families, demanding full accountability from the United States government,” Ben Crump Law, via AOL.com

A Historical Context of Medical Mistrust

The current allegations arrive against a backdrop of deep-seated skepticism toward the American medical establishment within Black communities. This distrust is rooted in a long, documented history of exploitation where Black bodies were subjected to experimentation without consent. From the era of slavery, where medical treatment aboard ships was often characterized by violence, to the 20th century, the relationship between the medical industry and Black Americans has been marked by profound betrayal. Perhaps the most prominent example of this legacy is the Tuskegee Syphilis Study. As reported by USA Today, the U.S. Public Health Service recruited hundreds of impoverished African American men in 1932, withholding treatment for syphilis for 40 years even after a cure was readily available. The study only ended after it became front-page news in 1972, leading to a $10 million class-action settlement in 1975 and a formal presidential apology in 1997. Rana Hogarth, a history professor at the University of Illinois, emphasizes that while Tuskegee serves as a primary reference point for this mistrust, it represents only a fraction of a much wider pattern.

“When we talk about why Black people wouldn’t trust a medical establishment, a lot of people cite Tuskegee, which makes sense. But Tuskegee is not the start.” Rana Hogarth, University of Illinois, via USA Today

The Ongoing Challenge of Public Health Equity

The impact of these historical abuses continues to shape modern health outcomes. During the early stages of the COVID-19 pandemic, public health officials struggled to overcome vaccine hesitancy in communities of color, a challenge exacerbated by the historical memory of medical exploitation. Sandra Lindsay, the director of critical care nursing at Long Island Jewish Medical Center, became a symbol of this struggle when she received the first COVID-19 vaccine in December 2020. Lindsay acknowledged the heavy weight of history while attempting to bridge the gap between scientific necessity and community fear. Her perspective highlights the difficulty of reconciling current medical progress with past institutional harms.

“I thought about … stumping COVID, getting rid of it, so it can’t kill us anymore and rob us of our lives and our livelihoods,” Sandra Lindsay, Long Island Jewish Medical Center, via USA Today

Lindsay further noted the emotional and social complexity of her role as the first American to be vaccinated, stating, “I know just me getting the vaccine won’t erase the centuries of mistrust and any inhumane and harmful behaviors that have taken place. I know my one act of taking the vaccine won’t erase those fears.”

Legal Stakes and Future Implications

The lawsuit filed by the families of Hambrick and King represents a direct challenge to the federal government regarding its historical oversight of medical research. The legal team, which includes attorneys William H. Murphy Jr., Carol Lexing Powell, Malcolm P. Ruff, and Nabeha Shaer, is seeking both acknowledgment and compensation for the families who they say were kept in the dark for decades. As the litigation proceeds, the case will likely force a broader examination of how institutional research protocols were managed in the 1960s and the degree to which vulnerable populations were targeted. For the families involved, the filing is not merely a request for legal remedy but a demand for the accountability that has been absent for more than half a century. The case serves as a stark reminder that the wounds left by past medical practices remain active in the public consciousness, influencing how medical research is perceived and accepted today. Stakeholders in the medical and legal fields will be watching the proceedings in Washington, D.C., closely to see how the government responds to these specific allegations of state-sponsored experimentation.